Valeant, in its fight for Botox maker Allergan, is investing cash and time wooing the doctors it would need on its side after a takeover.
from WSJ.com: US Business http://ift.tt/1sFbBPR
via IFTTT
from WSJ.com: US Business http://ift.tt/1sFbBPR
via IFTTT
No comments:
Post a Comment